Hangzhou Adamerck Pharmlabs Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Hangzhou Adamerck Pharmlabs Inc. - overview
Established
2000
Location
Hangzhou, Zhejiang, China
Primary Industry
Biotechnology
About
Based in Zhejiang, China and founded in 2000, Hangzhou Adamerck Pharmlabs Inc. is a pharmaceutical enterprise, being dedicated to the research and development of innovative drug. The company was founded by Youmao Qi, a Doctor returned from overseas. Up to now, the company has declared more than 25 domestic patents for invention and 3 international patents for invention, developed 5 new drugs in State Category 1, and accomplished the registration of more than 100 projects to CFDA.
Adamerck has established research and development center and academician workstation including the screening platform for chemical drugs, natural drugs and medicinal preparations. The company also has a drug manufacturing base which is able to process APIs, solid preparations and injections. Muscle relaxant antagonist Aom0498 is the company first independent target muscle relaxant, which has entered the clinical trial stage. It is helpful for patients to restore spontaneous breathing after operation, it can also used to reduce side effects and emergency rescue.
The company also has other new drug projects such as Anti-thrombotic Aom0315, Intravenous anesthetic Aom0765 and Weight-Loss Drug Aom1110. The company's research involves drugs for anesthesia, cardiovascular system, weight loss, diabetes, hypnosis and tumor.
Current Investors
Zheda Zhenghe, Hangzhou Miyin Investment Management, Hangzhou Yuanhenglizhen Equity Investment Management
Primary Industry
Biotechnology
Sub Industries
Biopharmaceuticals
Website
www.adamerck.net
Company Stage
Series B
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.